Pombiliti 105 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - 25 Swissmedic Key 67804003 Registration Holder Amicus Therapeutics Switzerland GmbH Name Pombiliti 105 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung Date of registration 04.07.2024 Introduction of Sequence 04.07.2024 ATC-Classification (A16AB23) Revision date WHO WHO-DDD Valid until 03.07.2029 Index Therapeuticus (BSV) 07.14. Show package size 25 Index Therapeuticus (Swissmedic) 07.14. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680678040039 Medication Code Biotechnologika Pharmacode Disponibility
Composition cipaglucosidasum alfa 105 mg, natrii citras dihydricus corresp. natrium 10.5 mg, acidum citricum monohydricum, mannitolum, polysorbatum 80, pro vitro. Packungsbestandteile Galenic Form Excipiens BAG: Active Agent Dose 105 mg
Inactive agents Citric Acid Monohydrate Mannitol Natrii Citras Dihydricus Polysorbatum 80
Source Data was imported : 07.08.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
